NCT04396522View on ClinicalTrials.gov

Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia

CompletedOBSERVATIONAL
Enrollment

194

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

January 9, 2023

Study Completion Date

February 21, 2023

Conditions
Pneumonia
Interventions
DEVICE

noninvasively Bio-electrical Impedance Analysis (BIA)

By means of noninvasively Bio-electrical Impedance Analysis (BIA) to measure body composition, which divides body weight into different components such as lean body mass and fat mass.

Trial Locations (1)

83301

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT04396522 - Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia | Biotech Hunter | Biotech Hunter